Search clinical trials for: Therapeutic HBV Vaccine

Total 22554 results

African Malaria Network Trust

Unknown

Safety of Recombinant Hybrid GMZ 2 [GLURP + MSP 3] Blood Stage Malaria Vaccine

Malaria

Gabon
Critical Therapeutics

Terminated

Zileuton CR vs Placebo in Poorly Controlled Asthma Patients on Moderate Dose ICS

Asthma

United States
African Malaria Network Trust

Unknown

Safety and Immunogenicity of Apical Membrane Antigen 1 (PfAMA-1-FVO[25-545])

Malaria

Mali
Bayside Health
Gilead Sciences; Centre for Clinical Research Excellence in Infectious Diseases...

Unknown

HIV-HBV Co-Infection and Liver Disease

HIV Infections | HIV-HBV Co-Infection

Australia
Introgen Therapeutics

Unknown

Study to Compare the Overall Survival of Patients Receiving INGN 201 (Study Drug) With Patients Receiving Methotrexate

Carcinoma, Squamous Cell

United States
Introgen Therapeutics
M.D. Anderson Cancer Center

Unknown

Safety and Efficacy Study of INGN 241 Gene Therapy in Patients With In Transit Melanoma

Neoplasm Metastasis | Malignant Melanoma

United States
Introgen Therapeutics

Completed

Study to Determine the Efficacy and Safety of Docetaxel and Doxorubicin With INGN 201 in Locally Advanced Breast Cancer

Locally Advanced Breast Cancer (LABC)

United States
Abbott

Completed

Assessment of the Effect of Adalimumab on Response to Influenza Virus and Pneumococcal Vaccines in Subjects With Rheumatoid Arthritis

Rheumatoid Arthritis
Assistance Publique - Hôpitaux de Paris
Orakine Ltd, Dublin, Ireland

Terminated

Effect of the Interferon Alpha Citizen by Sub-Lingual Way on the Humoral Immunizing Answer (GP-INFA)

Influenza Infection

France
Tyco Healthcare Group

Unknown

ISIS 1 Therapeutic Effectiveness

OSAS (Obstructive Sleep Apneas Syndrome)

France
Assaf-Harofeh Medical Center

Unknown

The Influence of Probiotics on the Immunologic Response to Vaccinations in Infants

Measles | Rubella | Mumps | Immunity

Israel
Gilead Sciences

Completed

Open Label Study of Pharmacokinetics and Safety of Dose of Adefovir Dipivoxil in Children and Adolescents With HBV

Hepatitis B

Belgium, Germany, Poland, United Kingdom
Critical Therapeutics

Completed

Assessment of PFT, Safety, and PK of Zileuton Injection in Asthma Patients

Asthma
National Institute of Allergy and Infectious Diseases...

Completed

Safety of the EnvPro HIV Vaccine in Healthy Volunteers

HIV Infections

United States
French National Agency for Research on AIDS and...
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Antibody Responses to Pneumococcal Vaccines Among HIV-Infected Adults.

HIV Infections
Genitope Corporation

Terminated

Personalized Active Immunotherapy (Vaccine Therapy) and Sargramostim Given After Standard of Care Treatment With Rituximab and Chemotherapy for Initial Treatment With Lymphoma

Non-Hodgkin's Lymphoma

United States
Novartis
Novartis Vaccines

Completed

Study of the Safety, Tolerability and Immune Response of TBE Vaccines Administered to Healthy Children

Encephalitis, Tick-Borne

Germany
International Vaccine Institute
Wellcome Trust; Centers for Disease Control and Prevention; University of Western... and other collaborators

Completed

Typhoid Vi Vaccine Effectiveness in Hechi, Guangxi, China

Typhoid | Paratyphoid Fever

China
International Vaccine Institute
GlaxoSmithKline; Wellcome Trust; National Institute of Hygiene and Epidemiology... and other collaborators

Completed

Introduction of the Vi Polysaccharide Typhoid Vaccine in Hue City, Central Vietnam

Typhoid | Paratyphoid Fever

Vietnam
Aeris Therapeutics

Terminated

Israeli 10 mL Bronchoscopic Lung Volume Reduction (BLVR) Phase 1/2 Emphysema Study - Initial Formulation

Pulmonary Emphysema

Israel
Kaohsiung Medical University Chung-Ho Memorial...

Unknown

Genetic Polymorphisms of TNF-α Promoter and HBV Genotype on Outcome of HBV-Related Chronic Liver Disease

Hepatocellular Carcinoma | Chronic Liver Disease

Taiwan
Aeris Therapeutics

Completed

US 10 mL Biologic Lung Volume Reduction (BLVR) Phase 1 Emphysema Study

Pulmonary Emphysema

United States
NeurogesX

Completed

NGX-4010 for the Treatment of Postherpetic Neuralgia

Pain | Peripheral Nervous System Diseases | Neuralgia | Herpes Zoster | Shingles

United States
NeurogesX

Completed

Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy

HIV Infections | Pain | Peripheral Nervous System Diseases

United States
NeurogesX

Terminated

Study of NGX-4010 for Treatment of Painful HIV-Associated Neuropathy

HIV Infections | Pain | Peripheral Nervous System Diseases

United States
Aeris Therapeutics

Completed

US 10 mL Bronchoscopic Lung Volume Reduction (BLVR) Phase 1 Emphysema Study - Initial Formulation

Pulmonary Emphysema

United States
NeurogesX

Completed

Controlled Study of NGX-4010 for the Treatment of Postherpetic Neuralgia

Pain | Peripheral Nervous System Diseases | Neuralgia | Herpes Zoster

United States
National Institutes of Health Clinical Center (CC)

Completed

Plasmapheresis of Anthrax-Vaccinated Subjects for Production of Anthrax Immune Globulin

Anthrax

United States
National Cancer Institute (NCI)

Completed

A Phase I Study of gp100 Human Melanoma Peptide Vaccine With Incomplete Freund's Adjuvant

Melanoma

United States
National Institute of Allergy and Infectious Diseases...

Completed

Influenza Vaccine in HIV Infection: Immune Response and Effect on Viral Load

HIV Infection

United States
National Cancer Institute (NCI)

Completed

New Therapeutic Strategies for Patients With Ewing's Sarcoma Family of Tumors, High Risk Rhabdomyosarcoma, and Neuroblastoma

Neuroblastoma | Rhabdomyosarcoma | Ewing's Sarcoma

United States
National Institute of Dental and Craniofacial Research...

Completed

Structure and Functional Status of Parotid Glands Exposed to Therapeutic Irradiation

Radiation Injuries | Xerostomia

United States
National Institute of Allergy and Infectious Diseases...

Completed

Phase I Study of APL 400-003, a Candidate HIV Vaccine, in HIV-Negative Volunteers

Acquired Immunodeficiency Syndrome | HIV Infection

United States
National Cancer Institute (NCI)

Completed

Immunization of HLA-A201 Patients With Metastatic Melanoma Using a Combination of Immunodominant Peptides From Three Melanoma Antigens, MART-1, GP100 and Tyrosinase

Melanoma | Neoplasm Metastasis

United States
National Institutes of Health Clinical Center (CC)

Completed

Peptide Vaccine to Prevent Recurrence of Nasopharyngeal Cancer

Nasopharyngeal Neoplasms

United States
National Institute of Allergy and Infectious Diseases...

Completed

HIV-1 Vaccine Test in Uninfected Adult Volunteers

Healthy | HIV Seronegativity

United States
National Institute of Allergy and Infectious Diseases...

Completed

Phase I/II Trial of Modified Vaccinia Virus Ankara (MVA) Vaccine Against Smallpox

Healthy

United States
National Institute of Allergy and Infectious Diseases...

Completed

Phase I Trial of Smallpox Vaccine

Healthy

United States
National Institute of Allergy and Infectious Diseases...

Completed

Mechanisms of Allergen Immunotherapy

Hypersensitivity | Asthma

United States
National Institute of Allergy and Infectious Diseases...

Completed

Comparison of Immune Response to Booster Vaccines in Blood Transplant Patients and Healthy Volunteers

Healthy | Stem Cell Transplantation | Active Immunity

United States
National Institute of Allergy and Infectious Diseases...

Completed

Safety and Immunogenicity of a Vaccine for Cutaneous Leishmaniasis Using Recombinant Human Interleukin-12 and Aluminum Hydroxide Gel as Adjuvants

Cutaneous Leishmaniasis

United States
National Institute of Dental and Craniofacial Research...

Completed

Evaluation of Patients With Unusual Diagnostic or Treatment Considerations

Healthy | Tooth Disease

United States
National Cancer Institute (NCI)

Completed

Autologous T-Cell Transplantation and the Immunotherapy of Residual Disease in Breast Cancer: Pilot Study of Vaccine-Driven T-Cell Expansion in Patients Treated With Dose-Intensive Chemotherapy

Neoplasm Metastasis | Breast Neoplasm

United States
National Cancer Institute (NCI)

Completed

Prediction and Testing of Antigenic Sites of the AIDS Virus, HTLV-III Recognized by T Lymphocytes for the Development of Synthetic Vaccines

HIV Infections | Healthy

United States
National Institute on Deafness and Other Communication...

Completed

Vaccination for Middle Ear Infection

Otitis Media

United States
National Cancer Institute (NCI)

Completed

A Phase I Study of Recombinant Vaccinia Virus That Expresses Prostate Specific Antigen in Adult Patients With Adenocarcinoma of the Prostate

Prostatic Neoplasms

United States
National Cancer Institute (NCI)

Completed

Therapeutic Drug Monitoring and Viral Resistance Testing in the Treatment of HIV-Infected Children

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

Immune Response to Influenza Vaccine in HIV-Infected Individuals

HIV Infections

United States
National Cancer Institute (NCI)

Completed

Clinical Evaluation of a Laser Heated, Fiberoptic-Coupled Radiation Dose Verification System

Neoplasm

United States
National Institute of Allergy and Infectious Diseases...

Completed

Lamivudine and Adefovir to Treat Chronic Hepatitis B Infection in People With and Without HIV Infection

HIV Infections | Chronic Hepatitis B

United States

Search clinical trials for: Therapeutic HBV Vaccine

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Serbia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations